RecallDepth
Class II Terminated

Haloperidol Decanoate Injection 100 mg/mL, packaged in a) 1 mL single-dose vials (NDC 0703-7131-01), b) 5 mL multi-dose vials (NDC 0703-7133-01), Rx only, Teva Pharmaceuticals USA, Inc. North Wales, PA 19454.

This recall has been terminated (originally issued August 25, 2021).

Company
Teva Pharmaceuticals Usa
Recall Initiated
July 29, 2021
Posted
August 25, 2021
Recall Number
D-0732-2021
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
16,226 vials
Firm Location
Parsippany, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Lack of Assurance of Sterility

Distribution

Product was distributed Nationwide, including Puerto Rico.

Lot / Code Info

Lot #: a) 31327056B, exp. date 03/2022; 31328547B, exp. date 01/2023; b) 31327066B, exp. date 03/2022

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class II Drug recalls